Daniel P. Silver

Thomas Jefferson University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

32h-index10.6kcitations91works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

DNA Repair Mechanisms(32), BRCA gene mutations in cancer(22), Cancer Genomics and Diagnostics(18), Genetics and Neurodevelopmental Disorders(15), PARP inhibition in cancer therapy(15)

Publications91 total

<i>MECP2-</i> Dependent Cancers Can Be Targeted by Epigenetic Drugs: A New Role for Epigenetic Cancer Therapy
Molecular Cancer Therapeutics·2025
Abstract 7187: Epigenetic drugs inhibit the oncogenic activity of methyl CpG binding protein 2 (MECP2)
Cancer Research·2025
A comprehensive assessment of social determinants of health for metastatic breast cancer.
Journal of Clinical Oncology·2023· 1 cited
PARP Inhibitors for the Treatment of BRCA1/ 2-Mutated Metastatic Breast Cancer: A Systematic Review and Meta-analysis
Hematology/Oncology and Stem Cell Therapy·2023· 5 citedOpen Access
Data from &lt;i&gt;MECP2&lt;/i&gt; Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy
2023Open Access
Supplementary Methods from Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents
2023Open Access
Supplementary Figures S1 - S6 from &lt;i&gt;MECP2&lt;/i&gt; Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy
2023Open Access
Supplementary Methods from Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents
2023Open Access
Supplementary Methods from &lt;i&gt;MECP2&lt;/i&gt; Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy
2023Open Access
Supplementary Figures 1-7 from Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents
2023Open Access
Data from Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents
2023Open Access
Supplementary Methods from &lt;i&gt;MECP2&lt;/i&gt; Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy
2023Open Access
Supplementary Data from &lt;i&gt;MECP2&lt;/i&gt; Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy
2023Open Access
Data from &lt;i&gt;MECP2&lt;/i&gt; Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy
2023Open Access
Supplementary Tables S1 - S3 from &lt;i&gt;MECP2&lt;/i&gt; Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy
2023Open Access
Data from Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents
2023Open Access
Supplementary Data from &lt;i&gt;MECP2&lt;/i&gt; Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy
2023Open Access
Supplementary Tables S1 - S3 from &lt;i&gt;MECP2&lt;/i&gt; Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy
2023Open Access
Supplementary Figures S1 - S6 from &lt;i&gt;MECP2&lt;/i&gt; Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy
2023Open Access
Supplementary Figures 1-7 from Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents
2023Open Access
page 1 of 5Next →

Frequent Co-authors

David M. Livingston(11), Judy E. Garber(8), Nadine Tung(8), Zoltán Szállási(7), Andrea L. Richardson(7), Paula D. Ryan(6), Maysa Abu‐Khalaf(6), Zhigang C. Wang(5), Shridar Ganesan(5), Nicolai J. Birkbak(5), J. Dirk Iglehart(5), Rebecca Jaslow(5), Andrea L. Richardson(4), Eric P. Winer(4), Aron C. Eklund(4), Alexander Miron(4), Jean Feunteun(4), Zhenchao Zhang(4), Frederick Fellin(4), Ronald E. Myers(4)